Press release pertaining to audited financial results (standalone and consolidated) for the quarter and year ended March 31, 2026
SAGILITY · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.7 pts less than Nifty Smallcap 250 and 0.4 pts less than its IT Enabled Services peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Sagility Limited reported strong FY26 results with full-year revenue of ₹71,929 million (US$814 million), up 29.1% YoY (23.6% in constant currency). Organic growth for the year was 20.1%. Adjusted EBITDA stood at ₹18,200 million at 25.3% margin (vs 26.4% in FY25), with 23.9% YoY growth. Adjusted PAT reached ₹11,306 million at 15.7% margin, growing 39.5% YoY, while basic EPS rose 69.2% to ₹1.98. The company also announced a final dividend of ₹0.10 per share. Q4 saw revenue of ₹20,243 million (29.1% YoY) with adjusted PAT of ₹3,069 million, up 28.0%. Management cited disciplined growth, improved cost management, and continued deleveraging despite a challenging U.S. healthcare payer environment.
Sagility delivered robust double-digit revenue and PAT growth, indicating strong business momentum and market share gains in U.S. healthcare operations. EBITDA margin compression warrants monitoring — it suggests cost pressures partially offset revenue gains. The high EPS growth and dividend signal confidence in cash generation.